Deutsch | English

Current News

	Search for:		in:

Target:

Full text

Title

Company name

Division:

Country:

From:

To:

Operation:		OR		AND
Search for:		partial		exact

Overview

Companies

Countries

All

Business

Career

Cooperation

Finances

Laws

Manufacturing

Market

People

Politics

Price Development

Products

Research

Technology

Contact | Print version | Send article | RSS feed

NovaScreen Receives Wyeth Contract for High Throughput Screen

28 Jun 2006 - NovaScreen Biosciences Corporation, a Caliper Life Sciences Company, announced that Wyeth Pharmaceuticals, a division of Wyeth, has selected NovaScreen to conduct a high-throughput screening (HTS) campaign. As a result, NovaScreen will screen 500,000 compounds against an inflammatory target.

The HTS campaign combines NovaScreen's kinase profiling expertise with Caliper's LabChip(R) 3000 microfluidic screening platform, which utilizes electrophoretic separation of assay components to provide analytical quality data that is highly reproducible.

Additional information

Caliper Life Sciences, Inc.
Hopkinton, MA, United States of America

News

	28 Jan 2008 -	Caliper Creates Specialized ACES Team to Deliver Customized Technology Solutions
	21 Aug 2006 -	Xenogen Biosciences Announces Target Validation Collaboration Agreement with Schering-Plough
	18 Jul 2006 -	Caliper Life Sciences and Xenogen Schedule Stockholder Meetings to Approve Merger
more news